Samsung Medical Center
Samsung Medical Center
Seoul, Gangnamgu, South Korea1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients | non-small cell lung carcinoma | Active, not recruiting | Phase 2 | 2026-07-28 | NCT05463224 |